Article Sidebar
Published:
Dec 15, 2012
Keywords:
Somatostatin receptor-2, gastroenteropancreatic neuroendocrine tumors, prognosis, somatostatin analogues
How to Cite
YENİAY, L., GÜRCÜ, B., ÜNALP, Ömer, YILMAZ, F., NART, D., SÖZBİLEN, M., & ÇOKER, A. (2012). Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors. Turkish Journal of Gastroenterology, 23(6), 736–740. https://doi.org/10.4318/tjg.2012.0476
Main Article Content
Levent YENİAY
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Barış GÜRCÜ
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Ömer ÜNALP
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Funda YILMAZ
Departments of Pathology, Ege University School of Medicine, İzmir
Deniz NART
Departments of Pathology, Ege University School of Medicine, İzmir
Murat SÖZBİLEN
Department of General Surgery, Ege University School of Medicine, İzmir, Turkey
Ahmet ÇOKER
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors
Main Article Content
Levent YENİAY
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Barış GÜRCÜ
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Ömer ÜNALP
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
Funda YILMAZ
Departments of Pathology, Ege University School of Medicine, İzmir
Deniz NART
Departments of Pathology, Ege University School of Medicine, İzmir
Murat SÖZBİLEN
Department of General Surgery, Ege University School of Medicine, İzmir, Turkey
Ahmet ÇOKER
Departments of General Surgery and Pathology, Ege University School of Medicine, İzmir
